AVITA Medical, Inc. (ASX:AVH) Annual Report 2024



The latest annual report of AVITA Medical, Inc. (AVH) was published on 31 Dec 2024. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - AVH Annual Results

Amounts in USD

Total Revenue
$101.97M
Gross Profit
$60.63M
EBIT
$-38.84M
Net Tangible Assets
$-48.01M
Net Income
$-98.15M
Capital Expenditures
-

AVH Income Statement 2024 Annual Report

As per the latest Income Statement of AVH, the Net revenue increased by $25.32M (33%) compared to the previous period. The operating income in 2024 increased by - (-). The net income as per the annual report was $-98.15M which decreased by $-44.07M (-81%) compared to previous year.

Income Statement Report (2024/2023)

2024 2023
Total Revenue $101.97M $76.65M
Gross Profit $60.63M $60.63M
Operating Income - -
Income Before Tax - -
Net Income $-98.15M $-54.08M

Balance Sheet - AVH 2024 Annual Report

Read further: AVH Balance Sheet Detailed Analysis

The latest balance sheet from annual result of AVITA Medical, Inc. showed the company increased the cash on balance sheet by $0.00 (0%). The Net tangible assets of AVH on the balance sheet were at $-48.01M which is $0.00 (0%) more than previous annual report. The total stockholder equity also increased by - (-) compared to previous reporting period.

Balance Sheet Statement Report (2024/2023)

2024 2023
Cash $23.31M $23.31M
Total Assets - -
Long Term Debt - -
Total Liabilities $44.77M $44.77M
Total Shareholder Equity - -
Net Tangible Assets $-48.01M $-48.01M

Cash Flow Statement - AVH 2024 Annual Report

The 2024 annual cash flow statement of AVITA Medical, Inc. showed that the net income decreased by $-44.07M (-81%) compared to previous reporting period. Also the capital expenditure of AVH increased by - (-).

As of 2024, the total cash from investing activities was - and total cash from financing activities was -.

Cash Flow Statement Report (2024/2023)

2024 2023
Net Income $-98.15M $-54.08M
Capital Expenditures - -
Dividends Paid - -
Total Cash From From Investing Activities - -
Total Cash From From Financing Activities - -

AVITA Medical, Inc. Annual Report History

Income Statement

Income Statement history of AVITA Medical, Inc. (ASX:AVH)

31 Dec 2024 31 Dec 2023 31 Dec 2022 30 Jun 2020
Total Revenue $101.97M $76.65M $50.63M $19.71M
Cost Of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00
Research Development - - - -
Selling General Administrative - - - -
Non Recurring - - - -
Other Operating Expenses - - - -
Total Operating Expenses $0.00 $0.00 $0.00 $0.00
Operating Income - - - -
Total Other Income Expense Net - - - -
Ebit $0.00 $0.00 $0.00 $0.00
Interest Expense - - - -
Income Before Tax - - - -
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Minority Interest - - - -
Net Income From Continuing Ops - - - -
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income $-98.15M $-54.08M $-39.22M $-58.09M
Net Income Applicable To Common Shares - - - -

Balance Sheet Statement

Balance Sheet Statement history of AVITA Medical, Inc. (ASX:AVH)

31 Dec 2024 31 Dec 2023 31 Dec 2022 30 Jun 2020
Cash $23.31M $23.31M - -
Total Assets - - - -
Total Liab $44.77M $44.77M - -
Long Term Debt - - - -
Total Stockholder Equity - - - -
Net Tangible Assets $-48.01M $-48.01M - -

Cash Flow Statement

Cash Flow Statement history of AVITA Medical, Inc. (ASX:AVH)

31 Dec 2024 31 Dec 2023 31 Dec 2022 30 Jun 2020
Net Income $-98.15M $-54.08M - -
Capital Expenditures - - - -
Dividends Paid - - - -
Total Cashflows From Investing Activities - - - -
Total Cash From Financing Activities - - - -